{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:52:41Z","timestamp":1791330761959,"version":"4.3.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61124-2","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:53:44Z","timestamp":1783425224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility of comprehensive genomic profiling tests using MTB management system at a single center in Japan"],"prefix":"10.1038","volume":"16","author":[{"given":"Chie","family":"Sarudate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maako","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kawamorita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Niizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Komine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Ishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"9","key":"61124_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins, F. S. & Varmus, H. A new initiative on precision medicine. N. Engl. J. Med. 372(9), 793\u2013795 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"61124_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton, G. M. et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat. Biotechnol. 31(11), 1023\u20131031 (2013).","journal-title":"Nat. Biotechnol."},{"key":"61124_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.19.00291","volume":"3","author":"H Ebi","year":"2019","unstructured":"Ebi, H. & Bando, H. Precision oncology and the universal health coverage system in Japan. JCO Precis Oncol. 3, 1\u20133 (2019).","journal-title":"JCO Precis Oncol."},{"issue":"3","key":"61124_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/cas.14754","volume":"112","author":"Y Mukai","year":"2021","unstructured":"Mukai, Y. & Ueno, H. Establishment and implementation of cancer genomic medicine in Japan. Cancer Sci. 112(3), 970\u2013977 (2021).","journal-title":"Cancer Sci."},{"issue":"5","key":"61124_CR5","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1002\/cam4.5349","volume":"12","author":"H Shirota","year":"2023","unstructured":"Shirota, H. et al. Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study. Cancer Med. 12(5), 6170\u20136181 (2023).","journal-title":"Cancer Med."},{"key":"61124_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/PO.20.00495","volume":"5","author":"KL Larson","year":"2021","unstructured":"Larson, K. L. et al. Clinical outcomes of molecular tumor boards: A systematic review. JCO Precis Oncol. 5, 1122\u20131132 (2021).","journal-title":"JCO Precis Oncol."},{"key":"61124_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/PO.20.00261","volume":"5","author":"AOL Seet","year":"2021","unstructured":"Seet, A. O. L. et al. Individualized molecular profiling for allocation to clinical trials Singapore study-an Asian tertiary cancer center experience. JCO Precis Oncol. 5, 859\u2013875 (2021).","journal-title":"JCO Precis Oncol."},{"issue":"6","key":"61124_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s10038-023-01133-5","volume":"68","author":"M Kawamura","year":"2023","unstructured":"Kawamura, M. et al. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility. J. Hum. Genet. 68(6), 399\u2013408 (2023).","journal-title":"J. Hum. Genet."},{"issue":"D1","key":"61124_CR9","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum, M. J. et al. ClinVar: Public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44(D1), D862\u2013D868 (2016).","journal-title":"Nucleic Acids Res."},{"key":"61124_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00011","volume":"2017","author":"D Chakravarty","year":"2017","unstructured":"Chakravarty, D. et al. OncoKB: A precision oncology knowledge base. JCO Precis Oncol. 2017, 1\u201316 (2017).","journal-title":"JCO Precis Oncol."},{"issue":"D1","key":"61124_CR11","doi-asserted-by":"publisher","first-page":"D536","DOI":"10.1093\/nar\/gkaa1034","volume":"49","author":"S Tadaka","year":"2020","unstructured":"Tadaka, S. et al. jMorp updates in 2020: Large enhancement of multi-omics data resources on the general Japanese population. Nucleic Acids Res. 49(D1), D536\u2013D544 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"61124_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41576-020-0255-7","volume":"21","author":"L Koch","year":"2020","unstructured":"Koch, L. Exploring human genomic diversity with gnomAD. Nat. Rev. Genet. 21(8), 448 (2020).","journal-title":"Nat. Rev. Genet."},{"issue":"Database issue","key":"61124_CR13","doi-asserted-by":"publisher","first-page":"D652","DOI":"10.1093\/nar\/gkp995","volume":"38","author":"SA Forbes","year":"2010","unstructured":"Forbes, S. A. et al. COSMIC (the catalogue of somatic mutations in cancer): A resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 38(Database issue), D652\u2013D657 (2010).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"61124_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.3774","volume":"49","author":"M Griffith","year":"2017","unstructured":"Griffith, M. et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat Genet. 49(2), 170\u2013174 (2017).","journal-title":"Nat Genet."},{"issue":"11","key":"61124_CR15","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1158\/2159-8290.CD-22-0417","volume":"12","author":"T Kohno","year":"2022","unstructured":"Kohno, T. et al. C-CAT: The national datacenter for cancer genomic medicine in Japan. Cancer Discov. 12(11), 2509\u20132515 (2022).","journal-title":"Cancer Discov."},{"issue":"2","key":"61124_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s43018-022-00332-x","volume":"3","author":"D Tamborero","year":"2022","unstructured":"Tamborero, D. et al. The molecular tumor board portal supports clinical decisions and automated reporting for precision oncology. Nat. Cancer. 3(2), 251\u2013261 (2022).","journal-title":"Nat. Cancer."},{"issue":"12","key":"61124_CR17","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1111\/cas.15586","volume":"113","author":"H Ida","year":"2022","unstructured":"Ida, H. et al. Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice. Cancer Sci. 113(12), 4300\u20134310 (2022).","journal-title":"Cancer Sci."},{"issue":"11","key":"61124_CR18","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1111\/cas.15517","volume":"113","author":"K Sunami","year":"2022","unstructured":"Sunami, K. et al. Chronological improvement in precision oncology implementation in Japan. Cancer Sci. 113(11), 3995\u20134000 (2022).","journal-title":"Cancer Sci."},{"issue":"5","key":"61124_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jjco\/hyaa277","volume":"51","author":"J Kikuchi","year":"2021","unstructured":"Kikuchi, J. et al. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan. Jpn. J. Clin. Oncol. 51(5), 753\u2013761 (2021).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"12","key":"61124_CR20","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1111\/cas.15993","volume":"114","author":"I Fukada","year":"2023","unstructured":"Fukada, I. et al. Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice. Cancer Sci. 114(12), 4632\u20134642 (2023).","journal-title":"Cancer Sci."},{"issue":"3","key":"61124_CR21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/cas.16065","volume":"115","author":"H Kage","year":"2024","unstructured":"Kage, H. et al. Patient survey on cancer genomic medicine in Japan under the national health insurance system. Cancer Sci. 115(3), 954\u2013962 (2024).","journal-title":"Cancer Sci."},{"issue":"7","key":"61124_CR22","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1111\/cas.15833","volume":"114","author":"H Kage","year":"2023","unstructured":"Kage, H. et al. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan. Cancer Sci. 114(7), 3041\u20133049 (2023).","journal-title":"Cancer Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61124-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:25:36Z","timestamp":1791329136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61124-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61124"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61124-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5501115\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients obtained Informed consent for research, but more detailed study protocols were approved by the IRB through the disclosure of information. Approval of the research protocol and ethics by an Institutional Reviewer Board: IRB No. 2021-1-250 and 2023-1-1036.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31213"}}